Last update Nov. 24, 2023

D03AX12 ; M02AC

Compatible

Safe product and/or breastfeeding is the best option.

Trolamine is the salt formed by combining salicylic acid and triethanolamine. It is used to reduce certain skin stains, remove earwax, prevent radiation-induced dermatitis, as a sunscreen, topical analgesic balm and in cosmetics. Topical application.

At the time of the last update, we found no published data on its excretion in breast milk.

Cutaneous absorption is less than 10% (Hale, Cross 1998 & 1997, Morra 1996), so the levels reached in plasma are very low and passage into breast milk is not likely to be significant.

Trolamine salts may irritate the skin and mucous membranes and cause contact dermatitis.

Do not apply on the breast, or clean the breast and hands well before breastfeeding.

Alternatives

We do not have alternatives for D03AX12 ; M02AC since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

D03AX12 ; M02AC is Trolamine, Triethanolamine Salicylate in ATC Code/s.

Is written in other languages:

Groups

D03AX12 ; M02AC belongs to these groups or families:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. dermat: <10; oral: significant %
Molecular weight 287 daltons
Protein Binding 50 - 90 %
pKa 15.12 -
T½ 1 - 2 hours

References

  1. AEMPS. Trietanolamina (Bexidermil) Ficha técnica. 2022 Full text (in our servers)
  2. Cross SE, Anderson C, Roberts MS. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Br J Clin Pharmacol. 1998 Abstract Full text (in our servers)
  3. Cross SE, Anderson C, Thompson MJ, Roberts MS. Is there tissue penetration after application of topical salicylate formulations? Lancet. 1997 Abstract
  4. Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother. 1996 Abstract

Total visits

534

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM